Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors.
about
Methicillin-resistant Staphylococcus aureus (MRSA) detected at four U.S. wastewater treatment plantsCommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicRates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient populationThe evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance40 years of methicillin resistant Staphylococcus aureusAn outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureusSpread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA.Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection.The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.Nasal carriage of a single clone of community-acquired methicillin-resistant Staphylococcus aureus among kindergarten attendees in northern Taiwan.Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia.Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.The epidemiology of Staphylococcus aureus carriage in patients attending inner city sexually transmitted infections and community clinics in Calgary, Canada.A case control study of environmental and occupational exposures associated with methicillin resistant Staphylococcus aureus nasal carriage in patients admitted to a rural tertiary care hospital in a high density swine regionMolecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada.Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test.Low Prevalence of Community-Acquired Methicillin-Resistant Staphylococcus aureus in Adults at a University Hospital in the Central United States.Recognition of two groups of methicillin-resistant Staphylococcus aureus strains based on epidemiology, antimicrobial susceptibility, hypervariable-region type, and ribotype in FinlandSpinal epidural abscesses in children: a 15-year experience and review of the literature.Predictors of hospitals with endemic community-associated methicillin-resistant Staphylococcus aureus.High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infectionSevere Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates.Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia.[(18)F]FDG-6-P as a novel in vivo tool for imaging staphylococcal infections.Empyema thoracis: a 10-year comparative review of hospitalised children from south Asia.Isolation of Staphylococcus aureus and antibiotic-resistant Staphylococcus aureus from residential indoor bioaerosolsStaphylococcus aureus capsular polysaccharides.Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates.Staphylococcus aureus infections: transmission within households and the community.Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002.Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California.Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometryMethicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci in rural communities, western United States.Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay.Combined topical and oral antimicrobial therapy for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospitalized patients.Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility.In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia.The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections.
P2860
Q23919877-AB821393-06B6-400E-9E61-13EAB65BA4A3Q24614464-C838C51A-FD70-464E-B4AB-E67B84C4F574Q28182298-F85B3ACB-CCEB-42E5-8F1C-EA69B9D844D7Q28344792-DF2CE750-304D-4682-840B-773BC7A23112Q28359693-8EC6DC15-0622-468F-A386-12F36334BD18Q28366775-FC0C54D0-6F10-472B-8890-A3FB70408CDEQ30310977-B6FD14AC-B2F0-46B7-B2FC-9BDD027997A6Q30350496-D8B9A9B8-072A-43D6-B909-1F194EE515AEQ32092345-F3F0660C-03B0-4120-A700-A722BA5FA2C5Q33264579-253BB1E9-3FE7-49CD-85C5-A6E6B8C3B7ABQ33286437-85885927-3316-4DD7-B781-2FECE9482279Q33290348-9DBE10C0-199B-4625-B2B5-80A20D5DF8E0Q33719836-36299587-D744-4C82-9875-0F74CBE91775Q33728644-25B2E42E-3578-456D-96C3-877BF7055132Q33851432-E56FC105-5C76-4E2B-B1C7-C9E2DD3C3E67Q33856327-5F0700AA-851B-4309-A6BE-2856F69B1E25Q33963773-F9E352C9-8BEF-4D1A-8563-B670FFCF790EQ33972107-A2C11995-2CDA-4E8E-9698-0FC57338D6FDQ33972617-F9B638FB-2357-433A-B9E1-02C6B5E5029EQ34102322-1E6C6078-D1D3-4682-8108-7B9C2E1F39B3Q34118208-2DB3FADC-9F0A-4A1F-884F-7EE821FF1CECQ34233286-6E3140E3-348F-41D3-921A-19A991945891Q34267132-7F6EE9EB-5728-4491-9888-F6A9D176A8A9Q35163438-84153739-72D3-4658-9A7C-8419636008B3Q35267289-1721B34B-E853-43C2-827A-F9120F5F2C23Q35274484-A65EB9AF-E0A3-46BA-99AB-817A6B3F7631Q35573839-566462E9-0B82-432F-892B-0DD184611A45Q35630504-E35C4BF3-86E2-45B6-9A52-54F4780EA798Q35805583-FFAE1DF5-0FAB-4EAD-BF37-8D84EFFF64BEQ35815668-AF3665FA-C25A-45A8-A599-1440CB9C8C23Q35873382-D635EB14-21BC-4BAB-AD3D-9344A01FB618Q35913806-2CB30976-210C-439E-9B58-03972FA73786Q35922240-57EE3F6B-88B6-4D7A-853C-FA4746B01D81Q36009339-B40E3F4C-6179-427A-B9FA-B5AE1FFC70BCQ36009430-E88B2185-A24C-49D9-AC3A-988426DF18B8Q36170598-329DD6B8-00E3-492E-A86C-881DA883C972Q36170949-F11A388C-FA08-4618-935E-6041C783390DQ36172450-50B48976-5B16-4133-AFE7-755B6574A4CDQ36211152-A694B506-6E3D-444D-8A43-58A1D8AE9A8FQ36242617-24707C89-5286-4872-8865-0CC298DB988E
P2860
Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Community-acquired methicillin ...... en without known risk factors.
@ast
Community-acquired methicillin ...... en without known risk factors.
@en
type
label
Community-acquired methicillin ...... en without known risk factors.
@ast
Community-acquired methicillin ...... en without known risk factors.
@en
prefLabel
Community-acquired methicillin ...... en without known risk factors.
@ast
Community-acquired methicillin ...... en without known risk factors.
@en
P2093
P356
P1476
Community-acquired methicillin ...... en without known risk factors.
@en
P2093
P304
P356
10.1086/520437
P407
P577
1999-10-01T00:00:00Z